Takubo H - Search Results

1

[Long-term treatment of Parkinson's disease patients with selegiline hydrochloride (FPF 1100): outcome of 5-year treatment].

Kondo T, Takubo H, Yokochi F, Okuma Y, Mizuno Y. Kondo T, et al. Among authors: takubo h. No To Shinkei. 2002 Dec;54(12):1041-8. No To Shinkei. 2002. PMID: 12599519 Japanese.

2

[A long-term clinical effect of selegiline hydrochloride on Parkinson's disease].

Mizuno Y, Kondo T, Takubo H, Yokochi F. Mizuno Y, et al. Among authors: takubo h. No To Shinkei. 1994 May;46(5):465-71. No To Shinkei. 1994. PMID: 8060685 Clinical Trial. Japanese.

3

[A long-term clinical effect of selegiline hydrochloride on Parkinson's disease].

Mizuno Y, Kondo T, Takubo H, Yokochi F. Mizuno Y, et al. Among authors: takubo h. No To Shinkei. 1996 May;48(5):467-72. No To Shinkei. 1996. PMID: 8672306 Clinical Trial. Japanese.

4

[A 65-year-old man with Parkinsonism, gaze palsy, and dementia].

Mizuno Y, Yokochi F, Ohta S, Mori H, Takubo H. Mizuno Y, et al. Among authors: takubo h. No To Shinkei. 1996 Apr;48(4):381-93. No To Shinkei. 1996. PMID: 8679336 Japanese.

5

[A 62-year-old man with familial parkinsonism with the onset at 24 years of the age].

Takubo H, Kondo T, Mori H, Miyake T, Suda K, Yokochi M, Imai H, Mizuno Y. Takubo H, et al. No To Shinkei. 1996 Jun;48(6):587-97. No To Shinkei. 1996. PMID: 8703564 Japanese.

6

[A 74-year-old woman with parkinsonism and dementia who died four years after the onset].

Okuma Y, Hattori N, Nobukawa B, Mori H, Suda K, Takubo H, Mizuno Y. Okuma Y, et al. Among authors: takubo h. No To Shinkei. 1998 Jul;50(7):671-82. No To Shinkei. 1998. PMID: 9739528 Japanese.

7

Malignant syndrome in Parkinson's disease: concept and review of the literature.

Mizuno Y, Takubo H, Mizuta E, Kuno S. Mizuno Y, et al. Among authors: takubo h. Parkinsonism Relat Disord. 2003 Apr;9 Suppl 1:S3-9. doi: 10.1016/s1353-8020(02)00125-6. Parkinsonism Relat Disord. 2003. PMID: 12735909 Review.

8

A collaborative study on the malignant syndrome in Parkinson's disease and related disorders.

Takubo H, Harada T, Hashimoto T, Inaba Y, Kanazawa I, Kuno S, Mizuno Y, Mizuta E, Murata M, Nagatsu T, Nakamura S, Yanagisawa N, Narabayashi H. Takubo H, et al. Parkinsonism Relat Disord. 2003 Apr;9 Suppl 1:S31-41. doi: 10.1016/s1353-8020(02)00122-0. Parkinsonism Relat Disord. 2003. PMID: 12735913

9

Serum creatine kinase is elevated in patients with Parkinson's disease: a case controlled study.

Takubo H, Shimoda-Matsubayashi S, Mizuno Y. Takubo H, et al. Parkinsonism Relat Disord. 2003 Apr;9 Suppl 1:S43-6. doi: 10.1016/s1353-8020(02)00121-9. Parkinsonism Relat Disord. 2003. PMID: 12735914

10

Prevention and treatment of malignant syndrome in Parkinson's disease: a consensus statement of the malignant syndrome research group.

Ikebe S, Harada T, Hashimoto T, Kanazawa I, Kuno S, Mizuno Y, Mizuta E, Murata M, Nagatsu T, Nakamura S, Takubo H, Yanagisawa N, Narabayashi H. Ikebe S, et al. Among authors: takubo h. Parkinsonism Relat Disord. 2003 Apr;9 Suppl 1:S47-9. doi: 10.1016/s1353-8020(02)00123-2. Parkinsonism Relat Disord. 2003. PMID: 12735915 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters